To validate FGF-2’s role in non-NPC tumors, we chose T241 mouse fibrosarcoma cells and 4T1 mouse breast cancer cells and genetically propagated them to stably express human FGF-2 [24]. Here, FGF2 is linked to nasopharyngeal carcinoma.